Dopamine agonists and their role in Parkinson's disease treatment
10.1586/14737175.3.6.805
Saved in:
Main Author: | Tan E.-K. |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Review |
Published: |
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/149850 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Choosing dopamine agonists in Parkinson's disease
by: Tan E.-K., et al.
Published: (2018) -
Peripheral edema and dopamine agonists in Parkinson disease [5]
by: Tan E.-K.
Published: (2018) -
Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson's disease: An open-label study
by: Kim J.-M., et al.
Published: (2018) -
The role of tyrosine hydroxylase-dopamine pathway in Parkinson's disease pathogenesis
by: Zhou, Zhi Dong, et al.
Published: (2023) -
Dopamine transporter neuroimaging accurately assesses the maturation of dopamine neurons in a preclinical model of Parkinson's disease
by: Goggi, J.L., et al.
Published: (2021)